Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Clinical Pharmacology|February 1, 1982
Effect of food on the bioavailability of captopril in healthy subjectsS M Singhvi, D N McKinstry, J M Shaw, et al.British Journal of Clinical Pharmacology|January 1, 1979
Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertensionH R Brunner, H Gavras, B Waeber, et al.British Journal of Clinical Pharmacology|January 1, 1979
beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulationN K Hollenberg, D F Adams, D N McKinstry, et al.Clinical Pharmacology and Therapeutics|May 1, 1980
Disposition of captopril in normal subjectsK J Kripalani, D N McKinstry, S M Singhvi, et al.Drug Metabolism Reviews|January 1, 1984
Captopril: pharmacology, metabolism and dispositionB H Migdalof, M J Antonaccio, D N McKinstry, et al.Annals of Internal Medicine|January 1, 1979
Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patientsH R Brunner, H Gavras, B Waeber, et al.Journal of Clinical Pharmacology|January 1, 1978
Pharmacokinetics of iodamide in normal subjects and in patients with renal impairmentL T Difazio, S M Singhvi, A F Heald, et al.The New England Journal of Medicine|May 4, 1978
Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in manH Gavras, H R Brunner, G A Turini, et al.Hypertension (Dallas, Tex. : 1979)|July 1, 1979
Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitorJ M Sullivan, B A Ginsburg, T E Ratts, et al.Pageof 2